FINWIRES · TerminalLIVE
FINWIRES

European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading

-- European equities traded in the US as American depositary receipts were higher late Wednesday morning, edging up 0.12% to 1,808.88 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by oil and gas firm Eni (E) and semiconductor firm Sequans Communications (SQNS), which rose 1.8% and 1.5% respectively. They were followed by 3D printer company Materialise (MTLS) and internet advertising firm Criteo (CRTO), which were up 1.1% and 0.7% respectively.

The decliners from continental Europe were led by telecommunications company Nokia (NOK) and Ascendis Pharma (ASND), which fell 4.1% and 4% respectively. They were followed by medical device maker EDAP TMS (EDAP) and biotech firm Evaxion (EVAX), which were down 1.8% and 0.2% respectively.

The gainers from the UK were led by mining company BHP Group (BHP) and pharmaceutical company Silence Therapeutics (SLN), which advanced 3% and 2.9% respectively. They were followed by utilities company National Grid (NGG) and telecommunications operator Vodafone (VOD), which increased 2.8% and 1.6% respectively.

The decliners from the UK and Ireland were led by Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which dropped 3.8% and 3.4% respectively. They were followed by alcoholic beverage company Diageo (DEO) and hospitality company InterContinental Hotels Group (IHG), which lost 1.8% and 1.4% respectively.

Related Articles

Australia

Community Health Systems Shares Fall After Q1 Loss Widens, Revenue Falls

Community Health Systems (CYH) shares were down 15.5% after the company reported a wider Q1 adjusted net loss and lower revenue.The company reported a Q1 adjusted net loss Wednesday of $0.48 per diluted share, widening from a loss of $0.03 a year earlier.Analysts polled by FactSet expected a loss of $0.11.Net operating revenue for the quarter ended March 31 was $2.97 billion, down from $3.16 billion a year earlier.Analysts expected revenue of $2.95 billion.Community Health reiterated its full-year 2026 guidance, projecting a net loss ranging from $0.60 per share to breakeven. Analysts surveyed by FactSet expect a net loss of $0.39. The company also reaffirmed net operating revenue guidance of $11.6 billion to $12 billion. Analysts expect $11.65 billion.Price: $2.62, Change: $-0.48, Percent Change: -15.48%

$CYH
Australia

Market Chatter: Netflix in Talks to Buy Los Angeles Movie Studio Space

Netflix (NFLX) is in talks to purchase a historic Los Angeles movie studio space for a fragment of its 2021 sale price of $1.85 billion, after the property was repossessed by lenders including Goldman Sachs (GS), Bloomberg reported Tuesday, citing people familiar with the discussions.The final price for Radford Studio Center has not been decided yet, with one person involved in the talks mentioning that the potential price will be less than one-third of the 2021 price, the report said.Hackman Capital Partners, who currently own the property, defaulted on $1.11 billion of debt and handed over the property to lenders including Goldman Sachs after it failed to reach a refinancing deal last year, according to the news outlet.Netflix and Goldman Sachs did not immediately respond to' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $93.11, Change: $+0.53, Percent Change: +0.57%

$GS$NFLX
Mining & Metals

VVT Med Closes First Tranche In Private Placement of Units

VVT Med (VVTM.V) completed the first tranche of its previously announced non-brokered private placement offering for gross proceeds of up to $3 million, having issued 4,262,654 units at a price of $0.25 each for gross proceeds of $1.065 million, it said Wednesday.Each unit consists of one common share and one-half of one common share purchase warrant with each whole warrant exercisable into one common share at an exercise price of $0.375 per warrant share for a two-year period from the date of issuance, it added.Proceeds will be used to support expanded U.S. and global commercialization efforts, product manufacturing to accommodate anticipated demand, working capital and general corporate needs, it said, before adding closing it anticipates closing a second tranche of the offering in due course.The company's shares last traded Apr. 20, closing at $0.23 on the TSX Venture Exchange.

$VVTM.V